Growth stocks can be some of the most exciting picks in the market, as these high-flyers can captivate investors' attention, and produce big gains as well. However, they can also lead on the downside when the growth story is over, so it is important to find companies which are still seeing strong growth prospects in their businesses.
One such company that might be well-positioned for future earnings growth is Five Below Inc (NASDAQ: FIVE ). This firm, which is in the Retail - Miscellaneous industry, saw EPS growth of 200% last year, and is looking great for this year too.
In fact, the current growth estimate for this year calls for earnings-per-share growth of 38.1%. Furthermore, the long-term growth rate is currently an impressive 26.5%, suggesting pretty good prospects for the long haul.
Five Below, Inc. Price and Consensus
And if this wasn't enough, the stock has actually seen estimates rise over the past month for the current fiscal year by about 1%. Thanks to this rise in earnings estimates, FIVE has a Zacks Rank #1 (Strong Buy) which further underscores the potential for outperformance in this company. You can see the complete list of today's Zacks #1 Rank stocks here .
So if you are looking for a fast growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider FIVE. Not only does it have double-digit earnings growth prospects, but its impressive Zacks Rank suggests that analysts believe better days are ahead for FIVE as well.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
More From InvestorPlace
- 5 Reasons Why Dividend Growth Investing Should Be Your New Year's Resolution
- 27 Quotes From Investing Greats to Make You a Better Dividend Investor
- 7 Tech Stocks Chase Coleman Is Buying Heading Into 2018
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.